Tetrahydroisoquinolnyl sulfamic acids
   
   

Compounds of formula (I): 1 are effective in the treatment of protein tyrosine phosphatase (PTPase) mediated disorder such as diabetes.

 
Web www.patentalert.com

< Treatment of statin side effects using uridine derivatives

< Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an acetylcholinesterase inhibitor

> Substituted cyclic amine metalloprotease inhibitors

> Heterocyclic compounds useful as growth hormone secretagogues
~ 00194